ZEB1 and melanoma: The transcription factor ZEB1 is a known inducer of mesenchymal–epithelial transition and invasiveness; in melanoma, elevated ZEB1 levels are associated with resistance to treatment with MAPK inhibitors [99], while the ZEB1/ZEB2 ratio would mediate phenotypic plasticity [46,99,100].